300452 山河药辅
已收盘 12-08 15:00:00
资讯
新帖
简况
山河药辅(300452)披露选举董事长及变更法定代表人公告,11月07日股价上涨0.87%
证券之星 · 11-07
山河药辅(300452)披露选举董事长及变更法定代表人公告,11月07日股价上涨0.87%
山河药辅股东计划在2026年2月21日之前减持最多3%股份
美股速递 · 10-31
山河药辅股东计划在2026年2月21日之前减持最多3%股份
山河药辅最新公告:股东复星医药拟减持不超3.00%股份
证券之星 · 10-31
山河药辅最新公告:股东复星医药拟减持不超3.00%股份
山河药辅(300452)2025年三季报简析:营收净利润同比双双增长
证券之星 · 10-22
山河药辅(300452)2025年三季报简析:营收净利润同比双双增长
山河药辅(300452)披露补选非独立董事公告,10月20日股价上涨1.9%
中金财经 · 10-20
山河药辅(300452)披露补选非独立董事公告,10月20日股价上涨1.9%
山河药辅(300452)9月30日股东户数1.91万户,较上期增加9.06%
证券之星 · 10-20
山河药辅(300452)9月30日股东户数1.91万户,较上期增加9.06%
山河药辅(300452.SZ)发布前三季度业绩,归母净利润1.33亿元,增长8.28%
智通财经 · 10-20
山河药辅(300452.SZ)发布前三季度业绩,归母净利润1.33亿元,增长8.28%
山河药辅(300452)披露控股股东变更公告,10月14日股价上涨0.7%
证券之星 · 10-14
山河药辅(300452)披露控股股东变更公告,10月14日股价上涨0.7%
山河药辅最新公告:控股股东、实际控制人由尹正龙变更为吴长虹
证券之星 · 09-29
山河药辅最新公告:控股股东、实际控制人由尹正龙变更为吴长虹
股市必读:山河药辅(300452)9月5日董秘有最新回复
证券之星 · 09-08
股市必读:山河药辅(300452)9月5日董秘有最新回复
山河药辅:新型药用辅料生产基地一期产能利用率约70-80%
证券之星 · 09-05
山河药辅:新型药用辅料生产基地一期产能利用率约70-80%
山河药辅(300452)2025年中报简析:增收不增利
证券之星 · 08-28
山河药辅(300452)2025年中报简析:增收不增利
药企龙头山河药辅突发公告,60岁董事长逝世,当日上午还在主持会议
21世纪经济报道 · 08-27
药企龙头山河药辅突发公告,60岁董事长逝世,当日上午还在主持会议
山河药辅:公司控股股东、实控人、董事长尹正龙逝世
金融界 · 08-27
山河药辅:公司控股股东、实控人、董事长尹正龙逝世
山河药辅表示董事长尹正龙于8月26日去世,经营不会受到影响
美股速递 · 08-27
山河药辅表示董事长尹正龙于8月26日去世,经营不会受到影响
山河药辅(300452.SZ)发布上半年业绩,归母净利润9303.52万元,下降2.61%
智通财经 · 08-26
山河药辅(300452.SZ)发布上半年业绩,归母净利润9303.52万元,下降2.61%
山河药辅(300452.SZ)新增1种药用辅料产品
智通财经 · 08-04
山河药辅(300452.SZ)新增1种药用辅料产品
山河药辅最新公告:与淮南经济技术开发区管理委员会签订高端辅料智造基地项目投资协议书
证券之星 · 07-31
山河药辅最新公告:与淮南经济技术开发区管理委员会签订高端辅料智造基地项目投资协议书
7月1日山河药辅(300452)龙虎榜数据:游资瑞鹤仙上榜
证券之星 · 07-01
7月1日山河药辅(300452)龙虎榜数据:游资瑞鹤仙上榜
【化学制药板块持续走高,山河药辅、灵康药业涨停】 化学制药板块持续走高,山河药辅、灵康药业涨停,北陆药业、翰宇药业、永安药业、星昊医药、哈三联等跟涨。
金融界 · 07-01
【化学制药板块持续走高,山河药辅、灵康药业涨停】 化学制药板块持续走高,山河药辅、灵康药业涨停,北陆药业、翰宇药业、永安药业、星昊医药、哈三联等跟涨。
加载更多
公司概况
公司名称:
安徽山河药用辅料股份有限公司
所属行业:
医药制造业
上市日期:
2015-05-15
主营业务:
安徽山河药用辅料股份有限公司的主营业务是药用辅料的研发、生产和销售。公司的主要产品是填充剂、黏合剂、崩解剂、润滑剂、包衣材料。“立崩”牌羧甲淀粉钠先后获得淮南市知名产品、安徽省名牌产品和“中国化学制药行业药用辅料优秀产品品牌”、首批“安徽工业精品”称号,羟丙甲纤维素荣获“中国化学制药行业优秀产品品牌”奖。微晶纤维素、硬脂酸镁和薄膜包衣粉产品被评定为淮南市知名产品,并有多个产品列入《中国高新技术产品出口目录》。公司多次获得“中国化学行业药用辅料优秀企业品牌”称号。
发行价格:
14.96
{"stockData":{"symbol":"300452","market":"SZ","secType":"STK","nameCN":"山河药辅","latestPrice":14.08,"timestamp":1765177437000,"preClose":14.2,"halted":0,"volume":5165430,"delay":0,"changeRate":-0.0085,"floatShares":234000000,"shares":234000000,"eps":0.5527,"marketStatus":"已收盘","change":-0.12,"latestTime":"12-08 15:00:00","open":14.21,"high":14.31,"low":14.01,"amount":72840600,"amplitude":0.0211,"askPrice":14.09,"askSize":77,"bidPrice":14.08,"bidSize":215,"shortable":0,"etf":0,"ttmEps":0.5527,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765243800000},"marketStatusCode":5,"adr":0,"adjPreClose":14.2,"symbolType":"stock","openAndCloseTimeList":[[1765157400000,1765164600000],[1765170000000,1765177200000]],"highLimit":15.62,"lowLimit":12.78,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":234449862,"isCdr":false,"pbRate":3.57,"roa":"--","peRate":25.474941,"roe":"13.69%","epsLYR":0.51,"committee":-0.327175,"marketValue":3301000000,"turnoverRate":0.0221,"status":1,"floatMarketCap":3296000000},"requestUrl":"/m/hq/s/300452","defaultTab":"news","newsList":[{"id":"2581881591","title":"山河药辅(300452)披露选举董事长及变更法定代表人公告,11月07日股价上涨0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581881591","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581881591?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:38","pubTimestamp":1762526303,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,山河药辅报收于13.88元,较前一交易日上涨0.87%,最新总市值为32.54亿元。该股当日开盘13.67元,最高13.94元,最低13.65元,成交额达7142万元,换手率为2.76%。公司于近日召开第六届董事会第九次会议,审议通过选举吴长虹女士为公司第六届董事会董事长,任期至本届董事会任期届满。此外,吴长虹女士当选董事会战略与投资委员会主任委员及提名委员会委员。上述事项表决结果均为同意8票,反对0票,弃权0票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700039410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0177","BK0239","300452"],"gpt_icon":0},{"id":"1105630925","title":"山河药辅股东计划在2026年2月21日之前减持最多3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1105630925","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105630925?lang=zh_cn&edition=full","pubTime":"2025-10-31 20:22","pubTimestamp":1761913329,"startTime":"0","endTime":"0","summary":"山河药辅表示,其股东计划在2026年2月21日之前,于11月24日与该日期之间减持最多3%的股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2579616314","title":"山河药辅最新公告:股东复星医药拟减持不超3.00%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2579616314","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579616314?lang=zh_cn&edition=full","pubTime":"2025-10-31 20:19","pubTimestamp":1761913166,"startTime":"0","endTime":"0","summary":"山河药辅(300452.SZ)公告称,持股9.23%的股东上海复星医药产业发展有限公司因自身资金需求,计划以集中竞价交易和大宗交易方式合计减持不超过697.87万股,占公司总股本的3.00%。减持期间为公告发布之日起15个交易日后的90日内(2025年11月24日至2026年2月21日)。在任意连续90日内,大宗交易减持不超过公司总股本的2%(465.25万股),集中竞价交易减持不超过公司总股本的1%(232.62万股)。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100046099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02196","BK0012","BK0188","600196","BK0060","BK0096","BK1515","BK0183","BK1593","BK0028","BK0177","BK0239","300452","BK1191","BK0187","BK0196","BK0175"],"gpt_icon":0},{"id":"2577835153","title":"山河药辅(300452)2025年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2577835153","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577835153?lang=zh_cn&edition=full","pubTime":"2025-10-22 06:04","pubTimestamp":1761084260,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期山河药辅发布2025年三季报。根据财报显示,山河药辅营收净利润同比双双增长。截至本报告期末,公司营业总收入6.97亿元,同比上升8.09%,归母净利润1.33亿元,同比上升8.28%。按单季度数据看,第三季度营业总收入2.26亿元,同比上升16.06%,第三季度归母净利润3952.88万元,同比上升46.99%。本次财报公布的各项数据指标表现尚佳。去年的净利率为13.66%,算上全部成本后,公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200004519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300452"],"gpt_icon":0},{"id":"2576832926","title":"山河药辅(300452)披露补选非独立董事公告,10月20日股价上涨1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576832926","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576832926?lang=zh_cn&edition=full","pubTime":"2025-10-20 17:22","pubTimestamp":1760952126,"startTime":"0","endTime":"0","summary":"公司近日发布公告称,安徽山河药用辅料股份有限公司于2025年10月20日召开第六届董事会第八次会议,审议通过《关于补选公司第六届董事会非独立董事的议案》。经董事会提名,吴长虹女士被提名为第六届董事会非独立董事候选人,任期自股东大会审议通过之日起至第六届董事会届满之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251020/31721004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0177","300452","BK0239"],"gpt_icon":0},{"id":"2576834487","title":"山河药辅(300452)9月30日股东户数1.91万户,较上期增加9.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576834487","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576834487?lang=zh_cn&edition=full","pubTime":"2025-10-20 17:07","pubTimestamp":1760951252,"startTime":"0","endTime":"0","summary":"证券之星消息,近日山河药辅披露,截至2025年9月30日公司股东户数为1.91万户,较6月30日增加1584.0户,增幅为9.06%。在化学制药行业个股中,山河药辅股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.24万户。从股价来看,2025年6月30日至2025年9月30日,山河药辅区间涨幅为5.22%,在此期间股东户数增加1584.0户,增幅为9.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000021228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300452","BK0177"],"gpt_icon":0},{"id":"2576831189","title":"山河药辅(300452.SZ)发布前三季度业绩,归母净利润1.33亿元,增长8.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576831189","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576831189?lang=zh_cn&edition=full","pubTime":"2025-10-20 16:42","pubTimestamp":1760949772,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)发布2025年三季度报告,该公司前三季度营业收入为6.97亿元,同比增长8.09%。归属于上市公司股东的净利润为1.33亿元,同比增长8.28%。归属于上市公司股东的扣除非经常性损益的净利润为1.2亿元,同比增长14.02%。基本每股收益为0.57元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357064.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300452"],"gpt_icon":0},{"id":"2575021418","title":"山河药辅(300452)披露控股股东变更公告,10月14日股价上涨0.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575021418","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575021418?lang=zh_cn&edition=full","pubTime":"2025-10-14 22:48","pubTimestamp":1760453295,"startTime":"0","endTime":"0","summary":"截至2025年10月14日收盘,山河药辅报收于12.99元,较前一交易日上涨0.7%,最新总市值为30.46亿元。公告披露,原控股股东、实际控制人尹正龙先生于2025年8月26日逝世,其持有的63,057,454股股份由其妻吴长虹、女尹稚雅依法继承。本次权益变动后,吴长虹直接持有公司20.172%股份,尹稚雅持有6.724%股份,二人已签署表决权委托协议,吴长虹实际拥有公司26.896%的表决权,成为公司新的控股股东及实际控制人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400065701.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2571335393","title":"山河药辅最新公告:控股股东、实际控制人由尹正龙变更为吴长虹","url":"https://stock-news.laohu8.com/highlight/detail?id=2571335393","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571335393?lang=zh_cn&edition=full","pubTime":"2025-09-29 20:20","pubTimestamp":1759148404,"startTime":"0","endTime":"0","summary":"山河药辅(300452.SZ)公告称,公司原控股股东、实际控制人尹正龙逝世后,其妻吴长虹和女儿尹稚雅通过继承获得公司股份。本次权益变动后,吴长虹将直接持有山河药辅20.172%股份,尹稚雅直接持有6.724%股份。同时,吴长虹与尹稚雅签署了《表决权委托协议》,尹稚雅将其所持有山河药辅全部股份的身份性权利,包括参会权、提名权、提案权、表决权等身份性权利全部委托吴长虹行使。山河药辅控股股东、实际控制人由尹正龙变更为吴长虹。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900031820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2565524782","title":"股市必读:山河药辅(300452)9月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2565524782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565524782?lang=zh_cn&edition=full","pubTime":"2025-09-08 03:20","pubTimestamp":1757272824,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘,山河药辅报收于13.54元,上涨1.5%,换手率2.68%,成交量5.01万手,成交额6736.34万元。董秘最新回复投资者: 1、新型药用辅料系列生产基地一期项目,目前的产能利用率多少?至于剩余100亩的预留项目,待五年后届时再根据行业发展和市场情况进行研究决定是否投资,具有不确定。当日关注点来自交易信息汇总:9月5日主力资金净流出729.31万元,散户资金净流入560.18万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800000876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2565535979","title":"山河药辅:新型药用辅料生产基地一期产能利用率约70-80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565535979","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565535979?lang=zh_cn&edition=full","pubTime":"2025-09-05 11:37","pubTimestamp":1757043430,"startTime":"0","endTime":"0","summary":"证券之星消息,山河药辅09月05日在投资者关系平台上答复投资者关心的问题。山河药辅回复:投资者你好,公司新型药用辅料系列生产基地一期项目目前产能使用率较高,约为70-80%左右。规划中的高端辅料智能生产线,首期项目用地约100亩,固定资产投资约为3亿元,上马的品种仍然是公司的主要品种。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500015500.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300452","BK0177"],"gpt_icon":0},{"id":"2562677655","title":"山河药辅(300452)2025年中报简析:增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2562677655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562677655?lang=zh_cn&edition=full","pubTime":"2025-08-28 06:28","pubTimestamp":1756333712,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期山河药辅发布2025年中报。根据财报显示,山河药辅增收不增利。截至本报告期末,公司营业总收入4.71亿元,同比上升4.65%,归母净利润9303.52万元,同比下降2.61%。按单季度数据看,第二季度营业总收入2.23亿元,同比上升5.06%,第二季度归母净利润4585.83万元,同比上升0.31%。本次财报公布的各项数据指标表现一般。投资活动产生的现金流量净额变动幅度为-176.15%,原因:本报告期购买理财产品支付现金及建设工程项目支付资金增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800006446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300452","BK0239","BK0177"],"gpt_icon":0},{"id":"2562910917","title":"药企龙头山河药辅突发公告,60岁董事长逝世,当日上午还在主持会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2562910917","media":"21世纪经济报道","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562910917?lang=zh_cn&edition=full","pubTime":"2025-08-27 13:37","pubTimestamp":1756273020,"startTime":"0","endTime":"0","summary":" 27日上午,山河药辅突发公告,公司控股股东、实际控制人、董事长尹正龙先生于2025年8月26日下午逝世,享年60岁。 21财经·南财快讯记者留意到,根据山河药辅发布的《第六届董事会第七次会议决议公告》,尹正龙逝世当日上午,还主持了公司第六届董事会第七次会议。 山河药辅表示,尹正龙所持的公司股份将按相关法律法规办理相关手续,公司将根据后续事项进展情况及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/s/2025-08-27/doc-infnkyff7470594.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-08-27/doc-infnkyff7470594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0177","BK0239","300452"],"gpt_icon":0},{"id":"2562534761","title":"山河药辅:公司控股股东、实控人、董事长尹正龙逝世","url":"https://stock-news.laohu8.com/highlight/detail?id=2562534761","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562534761?lang=zh_cn&edition=full","pubTime":"2025-08-27 08:22","pubTimestamp":1756254152,"startTime":"0","endTime":"0","summary":"山河药辅公告,公司控股股东、实控人、董事长尹正龙已于2025年8月26日下午逝世,享年60岁。尹正龙持有公司股份约6305.75万股,占公司股份总额的26.9%。尹正龙所持的公司股份将按相关法律法规办理相关手续,公司将根据后续事项进展情况及时履行信披义务。经全体董事推举,现由公司董事、总经理宋道才暂行行使公司董事长和法定代表人职责,直至公司董事会选举出新的董事长之日止。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/27082252721718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"1180223002","title":"山河药辅表示董事长尹正龙于8月26日去世,经营不会受到影响","url":"https://stock-news.laohu8.com/highlight/detail?id=1180223002","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180223002?lang=zh_cn&edition=full","pubTime":"2025-08-27 08:12","pubTimestamp":1756253536,"startTime":"0","endTime":"0","summary":"山河药辅表示董事长尹正龙于8月26日去世,经营不会受到影响","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0177","300452","BK0239"],"gpt_icon":0},{"id":"2562785413","title":"山河药辅(300452.SZ)发布上半年业绩,归母净利润9303.52万元,下降2.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562785413","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562785413?lang=zh_cn&edition=full","pubTime":"2025-08-26 16:27","pubTimestamp":1756196854,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)发布2025年半年度报告,该公司营业收入为4.71亿元,同比增长4.65%。归属于上市公司股东的净利润为9303.52万元,同比减少2.61%。归属于上市公司股东的扣除非经常性损益的净利润为8475.4万元,同比增长6.05%。基本每股收益为0.4元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1335237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300452"],"gpt_icon":0},{"id":"2556809041","title":"山河药辅(300452.SZ)新增1种药用辅料产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2556809041","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556809041?lang=zh_cn&edition=full","pubTime":"2025-08-04 16:37","pubTimestamp":1754296652,"startTime":"0","endTime":"0","summary":"智通财经APP讯,山河药辅(300452.SZ)公告,公司新增1种药用辅料产品:甘露醇丸芯获得国家药品监督管理局药品审评中心(简称“CDE”)的登记号,为F20250000241。甘露醇丸芯是由D-甘露糖醇及其他辅料制成的白色或类白色球形小丸,主要用作肠溶微丸制剂和缓控释微丸制剂的载体,也可直接作为药物微丸。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325349.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300452","BK0177","BK0239"],"gpt_icon":0},{"id":"2555788945","title":"山河药辅最新公告:与淮南经济技术开发区管理委员会签订高端辅料智造基地项目投资协议书","url":"https://stock-news.laohu8.com/highlight/detail?id=2555788945","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555788945?lang=zh_cn&edition=full","pubTime":"2025-07-31 18:31","pubTimestamp":1753957902,"startTime":"0","endTime":"0","summary":"山河药辅(300452.SZ)公告称,公司与淮南经济技术开发区管理委员会签订《高端辅料智造基地项目投资协议书》,拟在淮南经开化工园区投资建设高端辅料智造基地,项目投资额约10.5亿元人民币,其中固定资产投资6亿元人民币。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025073100031188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0177","300452"],"gpt_icon":0},{"id":"2548072859","title":"7月1日山河药辅(300452)龙虎榜数据:游资瑞鹤仙上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2548072859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548072859?lang=zh_cn&edition=full","pubTime":"2025-07-01 17:21","pubTimestamp":1751361714,"startTime":"0","endTime":"0","summary":"证券之星消息,沪深交易所2025年7月1日公布的交易公开信息显示,山河药辅因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月1日收盘,山河药辅报收于14.72元,上涨19.97%,涨停,换手率32.06%,成交量59.89万手,成交额8.58亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入833.62万元。瑞鹤仙等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100028970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300452","BK0177"],"gpt_icon":0},{"id":"2548403630","title":"【化学制药板块持续走高,山河药辅、灵康药业涨停】 化学制药板块持续走高,山河药辅、灵康药业涨停,北陆药业、翰宇药业、永安药业、星昊医药、哈三联等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2548403630","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548403630?lang=zh_cn&edition=full","pubTime":"2025-07-01 09:52","pubTimestamp":1751334762,"startTime":"0","endTime":"0","summary":"化学制药板块持续走高,山河药辅、灵康药业涨停,北陆药业、翰宇药业、永安药业、星昊医药、哈三联等跟涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/01095251401634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300016","BK0033","BK1574","300452","01477","BK0070","BK0239","002365","002900","BK0028","BK0056","159938","BK0060","BK0188","09939","BK1161","BK0086","BK1191","300199","BK1515","603669","BK0042","BK0177","BK0046","BK0077"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765190041137,"stockEarnings":[{"period":"1week","weight":-0.022},{"period":"1month","weight":0.0388},{"period":"3month","weight":0.0487},{"period":"6month","weight":0.141},{"period":"1year","weight":0.1401},{"period":"ytd","weight":0.2023}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":-0.0167},{"period":"3month","weight":0.0237},{"period":"6month","weight":0.1529},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1644}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽山河药用辅料股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"19072人(较上一季度增加9.06%)","perCapita":"12274股","listingDate":"2015-05-15","address":"安徽省淮南市大通区经济技术开发区河滨路2号","registeredCapital":"23444万元","survey":" 安徽山河药用辅料股份有限公司的主营业务是药用辅料的研发、生产和销售。公司的主要产品是填充剂、黏合剂、崩解剂、润滑剂、包衣材料。“立崩”牌羧甲淀粉钠先后获得淮南市知名产品、安徽省名牌产品和“中国化学制药行业药用辅料优秀产品品牌”、首批“安徽工业精品”称号,羟丙甲纤维素荣获“中国化学制药行业优秀产品品牌”奖。微晶纤维素、硬脂酸镁和薄膜包衣粉产品被评定为淮南市知名产品,并有多个产品列入《中国高新技术产品出口目录》。公司多次获得“中国化学行业药用辅料优秀企业品牌”称号。","listedPrice":14.96},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"山河药辅(300452)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供山河药辅(300452)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"山河药辅,300452,山河药辅股票,山河药辅股票老虎,山河药辅股票老虎国际,山河药辅行情,山河药辅股票行情,山河药辅股价,山河药辅股市,山河药辅股票价格,山河药辅股票交易,山河药辅股票购买,山河药辅股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"山河药辅(300452)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供山河药辅(300452)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}